Shanghai, China

Chuxiao Liu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chuxiao Liu: Innovator in Circular RNA Applications

Introduction: Chuxiao Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedical research, particularly in the application of circular RNA for therapeutic purposes. His innovative work aims to address complex medical conditions, showcasing his dedication to advancing healthcare solutions.

Latest Patents: Chuxiao Liu holds a patent titled "Application of circular RNA in preparing drug for treating systemic lupus erythematosus." This invention provides the use of a circular RNA with an incomplete double-stranded structure of 16 bp-33 bp in length, along with a promoting agent, in the preparation of a medicament for treating systemic lupus erythematosus. This groundbreaking work highlights the potential of circular RNA in developing new treatments for challenging diseases.

Career Highlights: Liu is affiliated with the Chinese Academy of Sciences, where he conducts research and develops innovative solutions in the field of medicine. His work has garnered attention for its potential impact on treating systemic lupus erythematosus, a condition that affects many individuals worldwide.

Collaborations: Chuxiao Liu collaborates with esteemed colleagues, including Lingling Chen and Li Yang. These partnerships enhance the research efforts and contribute to the advancement of knowledge in their respective fields.

Conclusion: Chuxiao Liu's contributions to the field of circular RNA applications demonstrate his commitment to innovation and improving healthcare outcomes. His work not only highlights the importance of research in medicine but also paves the way for future advancements in treating complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…